-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on Ardent Health, Lowers Price Target to $12

Benzinga·07/09/2026 17:23:55
Listen to the news
RBC Capital analyst Ben Hendrix maintains Ardent Health (NYSE:ARDT) with a Outperform and lowers the price target from $13 to $12.